GRMN
67
-4
MS
77
-2
JNPR
50
-6
DAL
84
-3
EQT
51
-3
NWS
75
-4
ECL
55
-2
AMAT
33
-13
GM
74
5
MDLZ
32
-4
WYNN
36
-5
APH
65
-3
PAYX
48
-6
EMR
71
-3
ADP
65
-3
HAL
48
-3
STI
45
26
DHI
44
-3
ESS
62
-3
SPG
60
2
GRMN
67
-4
MS
77
-2
JNPR
50
-6
DAL
84
-3
EQT
51
-3
NWS
75
-4
ECL
55
-2
AMAT
33
-13
GM
74
5
MDLZ
32
-4
WYNN
36
-5
APH
65
-3
PAYX
48
-6
EMR
71
-3
ADP
65
-3
HAL
48
-3
STI
45
26
DHI
44
-3
ESS
62
-3
SPG
60
2
Financhill
Back

Patria Latin American Opportunity Acquisition Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

PLAO
Patria Latin American Opportunity Acquisition

Last Price:
11.63
Seasonality Move:
1.89%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
33
Patria Latin American Opportunity Acquisition (PLAO) is a Sell

Is Patria Latin American Opportunity Acquisition a Buy, Sell or Hold?

  • The current Patria Latin American Opportunity Acquisition [PLAO] share price is $11.63. The Score for PLAO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PLAO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PLAO Stock Price Chart

What is Patria Latin American Opportunity Acquisition's stock price today?

  • The Patria Latin American Opportunity Acquisition share price today is $11.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLAO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PLAO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 65.65 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.61 - 11.63) Buy
Bollinger Bands (100): (11.5 - 11.62) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PLAO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.63 Buy
20-day SMA: 11.62 Buy
50-day SMA: 11.61 Buy
200-day SMA: 11.44 Buy
8-day EMA: 11.63 Buy
20-day EMA: 11.62 Buy
50-day EMA: 11.6 Buy
200-day EMA: 11.43 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Patria Latin American Opportunity Acquisition Earnings Growth & PLAO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Patria Latin American Opportunity Acquisition Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):